You are here:About>Health>AIDS / HIV> Medication Information> Medication  Fact Sheets> Meds K - O> Maraviroc - Selzentry - Celsentri - HIV Medication - CCR5 Inhibitor
About.comAIDS / HIV

Maraviroc (Selzentry, Celsentri)

From Mark Cichocki, R.N.,
Your Guide to AIDS / HIV.
FREE Newsletter. Sign Up Now!
About.com Health's Disease and Condition content is reviewed by Susan Olender, MD
Classification:
Maraviroc is the first HIV medication from the new class of HIV drugs called CCR5 inhibitors. By blocking the CCR5 attachment receptor on the CD4 cell, Maraviroc prevents HIV from attaching to the CD4 cell, thus preventing HIV from infecting the cell.

Form:
  • 150mg tablets
  • 300mg tablets

Dosage:

Instructions:
  • Maraviroc can be taken with or without food.
  • Maraviroc is taken as part of a HIV medication combination regimen.
  • Doses should be taken around the same times each day, about 12 hours apart.
  • It should be taken exactly as prescribed without missing or skipping doses.

Side Effects To Report To Your Doctor:

Clinical trials have shown that the most common side effects most common with Maraviroc include:

  • cough
  • fever
  • upper respiratory infections
  • rash
  • sore muscles
  • abdominal pain
  • dizziness

Important Warnings:
  • Maraviroc can increase the risk for heart problems such as heart attacks. Call your doctor or go to the emergency room if you experience chest pain, shortness of breath, neck or jaw pain, left arm pain, or feel like you are going to pass out.

  • Maraviroc can cause severe dizziness if you stand up too quickly.

  • Maraviroc can put stress on your liver. Call your doctor immediately if you develop yellowing skin or eyes, dark urine, abdominal pain, or vomiting.

Drug Interactions:

There are no known drug interactions with other HIV medications. However, there may be interactions with over-the-counter medications. Inform your doctor of all prescription and non-prescription drugs you are taking before starting Maraviroc.

More Information:

For more information about Maraviroc:

Source:

"Maraviroc (Selzentry, Celsentri) Fact Sheet #462"; AIDS Infonet; 16 Aug 2007.

Updated: September 25, 2007
About.com is accredited by the Health On the Net Foundation, which promotes reliable and trusted online health information.
 All Topics | Email Article | Print this Page | |
Advertising Info | News & Events | Work at About | SiteMap | Reprints | HelpOur Story | Be a Guide
More from About, Inc.: Calorie Count Plus | UCompareHealthCare
User Agreement | Ethics Policy | Patent Info. | Corrections | Privacy Policy
©2008 About, Inc., A part of The New York Times Company. All rights reserved.